Financhill
Back

Arbutus Biopharma Vs. Belite Bio Industry Stock Comparison

Sell
43

ABUS
Arbutus Biopharma

Last Price:
$3.37
Seasonality Move:
1.12%
Sell
37

BLTE
Belite Bio

Last Price:
$56.01
Seasonality Move:
-15.34%
Sell
43
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.29. The Score for ABUS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Belite Bio (BLTE) is a Sell

Is Belite Bio a Buy, Sell or Hold?

  • The current Belite Bio [BLTE] share price is $56.00. The Score for BLTE is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BLTE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.29
    The current trend is relatively stagnant and ABUS is experiencing slight selling pressure.

BLTE Stock Price Chart

What is Belite Bio's stock price today?

  • The Belite Bio share price today is $56.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLTE is experiencing selling pressure, which indicates risk of future bearish movement.

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 46.68 Sell
Chaikin Money Flow: -48453 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.23 - 3.41) Sell
Bollinger Bands (100): (3.3 - 3.88) Sell

BLTE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.14 Sell
Relative Strength Index (14 RSI): 45.06 Sell
Chaikin Money Flow: -10342 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.19 - 58.77) Sell
Bollinger Bands (100): (52.68 - 71.86) Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.37 Sell
20-day SMA: 3.33 Sell
50-day SMA: 3.36 Sell
200-day SMA: 3.54 Sell
8-day EMA: 3.33 Sell
20-day EMA: 3.34 Sell
50-day EMA: 3.39 Sell
200-day EMA: 3.4 Sell

BLTE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 56.62 Sell
20-day SMA: 57.56 Sell
50-day SMA: 60.16 Sell
200-day SMA: 54.91 Buy
8-day EMA: 56.49 Sell
20-day EMA: 57.41 Sell
50-day EMA: 59.66 Sell
200-day EMA: 55.49 Buy

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.08 per share.

Belite Bio Earnings Growth & BLTE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.19 per share, and an increase next year of $0.88 per share.

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Belite Bio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):